AV
DXCM icon

ASR Vermogensbeheer’s DexCom DXCM Stock Holding History

ASR Vermogensbeheer’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Sell
3,820
-21,137
-85% -$1.41M ﹤0.01% 444
2026
Q1 		$1.57M Buy
24,957
+406
+2% +$28.3K 0.02% 384
2025
Q4 		$1.63M Sell
24,551
-202
-0.8% -$13.1K 0.02% 384
2025
Q3 		$1.67M Sell
24,753
-75
-0.3% -$5.93K 0.02% 380
2025
Q2 		$2.17M Sell
24,828
-91
-0.4% -$7.13K 0.03% 350
2025
Q1 		$1.7M Buy
+24,919
New +$2.03M 0.03% 356

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ASR Vermogensbeheer's DXCM Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its DexCom (DXCM) stake by 85% in Q2 2026, selling an estimated $1.41M and leaving 3,820 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #444.

ASR Vermogensbeheer first reported a position in DXCM in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.17M in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • ASR Vermogensbeheer held 3,820 shares of DexCom worth $257K as of Q2 2026.
  • ASR Vermogensbeheer sold 21,137 DexCom shares in Q2 2026, an estimated $1.41M.
  • DexCom made up ﹤0.01% of ASR Vermogensbeheer's portfolio in Q2 2026, its #444 holding.
  • ASR Vermogensbeheer first reported a position in DexCom in Q1 2025 and has held it in 6 quarters since.
  • ASR Vermogensbeheer's DexCom position peaked at $2.17M in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.